LEUXA 22.5 INJ

Product Description

• Prostate Cancer (men):It is used for the palliative treatment of advanced prostate cancer by reducing testosterone levels, which helps inhibit tumor growth and ease symptoms like difficulty in urination.
• Hormone-responsive Breast Cancer (women):It can be used to treat certain types of breast cancer in pre/perimenopausal women by lowering estrogen levels.
• Endometriosis (women):By reducing estrogen, it helps shrink the endometrial tissues growing outside the uterus, relieving pain and other symptoms.
• Uterine Fibroids (women):It is used to manage symptoms like heavy bleeding and pelvic pain by reducing the size of non-cancerous growths in the uterus.
• Central Precocious Puberty (children):It delays the onset of early puberty by suppressing the premature release of sex hormones.

• Side Effects:Common side effects can include hot flashes, injection site reactions (pain, redness, swelling), fatigue, muscle weakness, headaches, and mood swings.
• Bone Density:Long-term use may lead to decreased bone mineral density; doctors may recommend calcium and vitamin D supplements.
• Pregnancy and Contraception:The injection is contraindicated during pregnancy and breastfeeding as it can harm the fetus. Effective non-hormonal contraception methods must be used by both men and women during treatment to prevent pregnancy.
• Other Conditions:Patients with a history of diabetes, heart conditions, depression, or osteoporosis should use this medication with caution and inform their doctor.